Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.
Piqray plus Faslodex prolonged progression-free survival by five months in a Phase III study.
FDA approves immunotherapy plus targeted therapy combo for initial treatment of advanced renal cell carcinoma.
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
Doctors are more likely to order breast and colorectal cancer screenings earlier in the day.
Healthier choices and a bit of prep can reduce carcinogens and increase flavor.
The American Academy of Dermatology is marking Skin Cancer Awareness Month by asking, “Do you use protection?”
The justice recused himself from the case, saying the insurer’s denial of coverage of proton beam therapy was “immoral and barbaric.”
A low dose of platinum-based chemotherapy worked as well as higher doses for elderly and frail people with esophageal and stomach cancer.
All 12 treated children with NTKR, ROS1 or ALK gene abnormalities showed partial or compete tumor shrinkage.
Test your knowledge
Phil Catudal credits his early cancer experience with his motivational approach to wellness.
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations.
A recent article in The Atlantic explains and debunks a growing myth around food and cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.